ACADIA Pharmaceuticals-Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates (Revised)

Acadia Pharmaceuticals (ACAD) came out with fourth-quarter earnings of $0.17 per share, missing the Zacks Consensus Estimate of$ 0.19 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items. ACAD reported GAAP earnings per share of 86 cents in the quarter. This quarterly report represents an earnings surprise of -10.53%. A quarter ago, it was expected that this drugmaker would post earnings of$ 0.13 per share when it actually produced earnings ...